Rymner Marilyn M, Akhtar Naveed, Martin Coleman, Summers Debbie
University of Missouri-Kansas City School of Medicine, USA.
Mo Med. 2010 Sep-Oct;107(5):333-7.
Treatment of acute ischemic stroke is time dependent and technically challenging. Sixty-four percent of hospitals in the U.S. have never given intravenous (IV) tissue plasminogen activator (tPA) for stroke and 40% of the U.S. population lives in a county without a hospital that routinely treats eligible stroke victims with IV tPA. This, the second in a Missouri Medicine series on stroke, summarizes the available acute treatment options and the evolving role of neuro-imaging in directing therapeutic decisions.
急性缺血性中风的治疗具有时间依赖性且在技术上具有挑战性。美国64%的医院从未使用过静脉注射组织型纤溶酶原激活剂(tPA)治疗中风,40%的美国人口所在的县没有一家医院常规使用静脉注射tPA治疗符合条件的中风患者。这是《密苏里医学》中风系列文章中的第二篇,总结了现有的急性治疗选择以及神经影像学在指导治疗决策中不断演变的作用。